In prior years, Canadian Licensed Producers was the main topic of discussion in end of year, forward looking articles that we published on the cannabis industry.
International cannabis markets were a main topic of discussion in 2021 and we expect this aspect of the industry to be even more significant in 2022.
During the year, there was an increase in the number of states that reported to have generated more than $1 billion of sales of medical and recreational cannabis.
Today, we want to provide insight on the potential of certain international cannabis markets in 2022 and believe our readers should be aware of this vertical of the industry.
During the fourth calendar quarter, US cannabis stocks came under heavy pressure after the SAFE Banking Act was not included in the National Defense Authorization Act .
Earlier this year, we were surprised to learn that the governor of Alabama signed legislation to legalize medical cannabis.
During the last year, the Latin American cannabis industry reported impressive advancements and is an international region that we are closely following.
Mexico is considered to be the most attractive cannabis market in Latin America and we have noticed an increase in the number of companies that are focused on it.
It is only a matter of time until cannabis is legal in Mexico and we expect this to serve as a significant growth catalyst.
We believe that Khiron is well position to capitalize on Mexico and are favorable on the strategic relationships the company has formed so far.
Last month, Germany announced a major milestone and reported that its three political parties have agreed to regulate the distribution and sale of recreational cannabis.
Although most of the companies that are levered to the EU cannabis industry are Canadian LPs, we have noticed an uptick in the number of US MSOs that are focused on markets like Germany.
All information that we provide is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.